Business of Cannabis Europe
European Cannabis Stocks Review: FSA Makes ‘Final Call’ For Evidence As Cellular Goods’ Stock Recovers From Confusion Over Its Products’ Inclusion
THE fallout from the publication of the FSA’s Public List is continuing to be felt on the stock markets this
Ben Stevens
April 22, 2022
